This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Jul;4(3):220-1.

doi: 10.4103/0976-500X.114611.

Good! Is it the best???

Sandhiya Selvarajan¹, Steven Aibor Dkhar, Ajith Ananthakrishna Pillai

Affiliations

PMID: 23960432
PMCID: PMC3746310
DOI: 10.4103/0976-500X.114611

Good! Is it the best???

Sandhiya Selvarajan et al. J Pharmacol Pharmacother. 2013 Jul.

. 2013 Jul;4(3):220-1.

doi: 10.4103/0976-500X.114611.

Authors

Sandhiya Selvarajan¹, Steven Aibor Dkhar, Ajith Ananthakrishna Pillai

Affiliation

¹ Department of Clinical Pharmacology, JIPMER, Puducherry, India.

PMID: 23960432
PMCID: PMC3746310
DOI: 10.4103/0976-500X.114611

No abstract available

PubMed Disclaimer

Similar articles

[Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].
Watanabe N, Makino S, Kihara N, Fukuda T. Watanabe N, et al. Arerugi. 2008 Dec;57(12):1284-92. Arerugi. 2008. PMID: 19169083 Japanese.
Good, good, good... good vibrations: the best option for better bones?
Eisman JA. Eisman JA. Lancet. 2001 Dec 8;358(9297):1924-5. doi: 10.1016/S0140-6736(01)06975-6. Lancet. 2001. PMID: 11747912 Review. No abstract available.
Preferential hyperacuity perimeter in best vitelliform macular dystrophy.
Querques G, Atmani K, Bouzitou-Mfoumou R, Leveziel N, Massamba N, Souied EH. Querques G, et al. Retina. 2011 May;31(5):959-66. doi: 10.1097/IAE.0b013e3181f441c1. Retina. 2011. PMID: 21242858
Peer-selected "best papers"-are they really that "good"?
Wainer J, Eckmann M, Rocha A. Wainer J, et al. PLoS One. 2015 Mar 19;10(3):e0118446. doi: 10.1371/journal.pone.0118446. eCollection 2015. PLoS One. 2015. PMID: 25789480 Free PMC article.
Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.
Mitchell MC, Friedman LS, McClain CJ. Mitchell MC, et al. Clin Gastroenterol Hepatol. 2017 Jan;15(1):5-12. doi: 10.1016/j.cgh.2016.08.047. Clin Gastroenterol Hepatol. 2017. PMID: 27979049 Free PMC article. Review.

See all similar articles

References

1. Chaturvedi A, Singh Y, Chaturvedi H, Thawani V, Singla S, Parihar D. Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris. J Pharmacol Pharmacother. 2013;4:33–8. - PMC - PubMed
1. [Last accessed on 2013 Mar 19]. Available from: http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=3671&EncHid=... .
1. Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial. JAMA. 2004;291:309–16. - PubMed
1. Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L, ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: The ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol. 2006;48:566–75. - PubMed
1. Kosiborod M, Arnold SV, Spertus JA, McGuire DK, Li Y, Yue P, et al. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: Results from the TERISA randomized clinical trial (type 2 diabetes evaluation of ranolazine in subjects with chronic stable angina) J Am Coll Cardiol. 2013;61:2038–45. - PubMed

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- scite Smart Citations